| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.3M | -7.9% | -43.2% |
| Cost of Revenue | $3.9M | -25.5% | +0.5% |
| R&D Expense | $4.6M | +37.2% | +17.4% |
| SG&A Expense | $9.3M | -26.3% | -26.4% |
| Operating Income | -$12.9M | +18.7% | -11.9% |
| Pre-tax Income | -$23.1M | +5.9% | -43.3% |
| Net Income | -$23.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $120K | -86.1% | -9.8% |
| Accounts Receivable | $6.7M | -39.9% | -23.5% |
| Inventory | $2.6M | -41.9% | -35.3% |
| Current Assets | $10.6M | -38.6% | -26.9% |
| Total Assets | $114.2M | -5.0% | -11.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.2M | — | — |
| Capital Expenditures | $70K | — | — |
| Investing Cash Flow | $2.1M | — | — |
| Financing Cash Flow | $7.4M | — | — |
| Free Cash Flow | -$8.2M | — | — |
| +5.9% |
| -43.3% |
| EPS (Basic) | -$0.88 | +13.7% | -20.5% |
| EPS (Diluted) | -$0.88 | +13.7% | -20.5% |
| $65.3M |
| -5.7% |
| -14.3% |
| Long-term Debt | $35.7M | — | — |
| Total Liabilities | $134.3M | -7.9% | +20.4% |
| Stockholders' Equity | -$20.1M | +21.2% | -216.3% |